Skip to main content
. 2021 May 28;118(21):357–362. doi: 10.3238/arztebl.m2021.0129

Figure.

Figure

Overview of the study design

*1 For the evaluation of long-term use (3 years) the absence of cancer until the end of 2014 was required; follow-up started at the beginning of 2015.

*2 Depicted is the lag time of the main analysis (lag time of 1 year); for the evaluation of long-term use (3 years), no lag time was included.

*3 Data censored because of death, end of insurance cover, or end of study.